Aldolase potentiates DIDS activation of the ryanodine receptor in rabbit skeletal sarcoplasmic reticulum by Seo, In-Ra et al.
Biochem. J. (2006) 399, 325–333 (Printed in Great Britain) doi:10.1042/BJ20060701 325
Aldolase potentiates DIDS activation of the ryanodine receptor in rabbit
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DIDS (4,4′-di-isothiocyanostilbene-2,2′-disulfonate), an anion
channel blocker, triggers Ca2+ release from skeletal muscle SR
(sarcoplasmic reticulum). The present study characterized the
effects of DIDS on rabbit skeletal single Ca2+-release channel/
RyR1 (ryanodine receptor type 1) incorporated into a planar lipid
bilayer. When junctional SR vesicles were used for channel in-
corporation (native RyR1), DIDS increased the mean Po (open
probability) of RyR1 without affecting unitary conductance when
Cs+ was used as the charge carrier. Lifetime analysis of single
RyR1 activities showed that 10 µM DIDS induced reversible
long-lived open events (Po = 0.451 +− 0.038) in the presence of
10 µM Ca2+, due mainly to a new third component for both
open and closed time constants. However, when purified RyR1
was examined in the same condition, 10 µM DIDS became con-
siderably less potent (Po = 0.206 +− 0.025), although the caffeine
response was similar between native and purified RyR1. Hence
we postulated that a DIDS-binding protein, essential for the DIDS
sensitivity of RyR1, was lost during RyR1 purification. DIDS-
affinity column chromatography of solubilized junctional SR,
and MALDI–TOF (matrix-assisted laser-desorption ionization–
time-of-flight) MS analysis of the affinity-column-associated
proteins, identified four major DIDS-binding proteins in the SR
fraction. Among them, aldolase was the only protein that greatly
potentiated DIDS sensitivity. The association between RyR1
and aldolase was further confirmed by co-immunoprecipita-
tion and aldolase-affinity batch-column chromatography. Taken
together, we conclude that aldolase is physically associated with
RyR1 and could confer a considerable potentiation of the DIDS
effect on RyR1.
Key words: Ca2+-release channel, disulfonic stilbene derivative,
excitation–contraction coupling, ryanodine receptor (RyR),
skeletal muscle.
INTRODUCTION
The RyR (ryanodine receptor) in striated muscle is a high-con-
ductance Ca2+-release channel located in the terminal cisternae
of the SR (sarcoplasmic reticulum) [1–5]. In skeletal muscle
EC (excitation–contraction) coupling, membrane depolarization
induces activation of the dihydropyridine receptor/voltage sensor,
and the subsequent conformational change of RyR1 leads to an
opening of RyR1, the release of Ca2+ from the SR and hence
muscle contraction. In cardiac-type EC coupling, depolarization-
induced Ca2+ influx through the dihydropyridine receptor/L-type
Ca2+ channel induces Ca2+ release from the SR through RyR2
and, in turn, muscle contraction. The third RyR isoform, RyR3
is more ubiquitously expressed at a much lower level than the
other two isoforms, and exists in a wide range of cells, such as
Jurkat T-cells, parotid acinar cells, the central nervous system and
neonatal and adult skeletal muscle [6].
Disulfonic stilbene derivatives have been extensively used
as pharmacological probes to study the kinetics and molecular
structures of membrane transporters. For example, the transport
kinetics and structure of the SR Ca2+-ATPase [7] have been
examined using disulfonic stilbene derivatives. In striated muscle
cells, one of the disulfonic stilbene derivatives, DIDS (4,4′-di-iso-
thiocyanostilbene-2,2′-disulfonate), has been widely used to
study the roles and mechanisms of various ion transport in the
sarcolemma and the internal organelles. Kawasaki and Kasai [8]
first found that disulfonic stilbene derivatives could activate RyR1
in rabbit skeletal SR vesicles, as well as in an artificial lipid bilayer
membrane. It was observed that DIDS locked RyR1 in an open
state when Ba2+ was used as a charge carrier [8]. Zahradnikova
and Zahradnik [9] observed irreversible DIDS activation of RyR2
from dog heart, with no change in single-channel conductance,
leading to the proposal of a covalent modification of an amino
group residing in the gating structure of the channel by DIDS.
Irreversible modification by DIDS was also found in sheep
cardiac RyR2 [10,11]. Experiments using skeletal RyR1 showed
that activation of RyR1 by DIDS could be either reversible
or irreversible, depending on the experimental conditions, e.g.
the concentration and incubation time of DIDS and cytosolic
Ca2+ concentration [12]. Studies on frog muscle revealed that the
Po (open probability) was augmented by DIDS at 5–200 µM by
inducing a long-lived open state [13].
The effects of DIDS on RyRs make this compound a potentially
useful probe to elucidate the mechanism of RyR function. Two
studies have already used this compound to probe its interaction
with the RyR1 and two RyR1-associated proteins, calmodulin [14]
and a 30 kDa protein [15–18]. The 30 kDa protein was identified
as a calsequestrin-binding protein in rabbit skeletal SR and was
postulated to be a receptor for DIDS, implying that DIDS is bound
to RyR1 via the 30 kDa protein in rabbit skeletal muscle [17]. On
the other hand, the direct DIDS binding to RyR and covalent
modification of RyR by DIDS have been postulated to be the
underlying molecular mechanisms for DIDS activation of RyRs
[9–12].
Abbreviations used: 1D and 2D, one and two dimensional; DIDS, 4,4′-di-isothiocyanostilbene-2,2′-disulfonate; EC, excitation–contraction; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; HSR, heavy fraction of fragmented sarcoplasmic reticulum; IPG, immobilized pH gradient; MALDI–TOF,
matrix-assisted laser-desorption ionization–time-of-flight; PEG, poly(ethylene glycol); Po, open probability; RyR, ryanodine receptor; SR, sarcoplasmic
reticulum.
1 To whom correspondence should be addressed (email dhkim@gist.ac.kr).
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The increasing number of RyR activation mechanisms by DIDS
in the literature gave rise to the necessity for a systematic approach
to identify the DIDS receptor that confers DIDS sensitivity to
RyR. In the present study, we employed both functional and
biochemical tools in an effort to identify the molecular machinery
responsible for the activation of RyR1 by DIDS. We report here
the novel finding that the glycolytic enzyme aldolase is bound to




Mouse anti-RyR1 antibody (1:5000) was obtained from Affinity
BioReagent (Golden, CO, U.S.A.). The horseradish-peroxidase-
conjugated goat anti-mouse IgG antibody (1:5000) was obtained
from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.).
The goat anti-aldolase antibody was obtained from Chemicon
(Temecular, CA, U.S.A.). Chemiluminescent reagents for im-
munoblot analysis were obtained from Pierce (Rockford, IL,
U.S.A.). DIDS, protease inhibitors, aldolase [ 80% (w/w)
purity], GAPDH (glyceraldehyde-3-phosphate dehydrogenase)
[85% (w/w) purity], malate dehydrogenase [99 % (w/v) purity]
and adenylate kinase [99% (w/v) purity] were obtained from
Sigma (St. Louis, MO, U.S.A.). [3H]Ryanodine, CNBr-Sepharose
4B and Protein G–Sepharose 4 Fast Flow affinity beads
were obtained from Amersham Biosciences (Piscataway, NJ,
U.S.A.). Phospholipids were obtained from Avanti Polar Lipids
(Birmingham, AL, U.S.A.).
Preparation of junctional SR vesicles from rabbit skeletal muscle
A heavy fraction of fragmented SR (HSR) vesicles, containing
junctional SR, was prepared from rabbit fast-twitch back and leg
muscles as described previously [19].
Purification of Ca2+-release channel
RyR1 was isolated as described previously [20]. SR vesicles
(approx. 10 mg of protein) were solubilized in 10.5 ml of buffer
A [1 M NaC1, 0.1 mM EGTA, 0.2 mM Ca2+, 5 mM AMP, 1 mM
dithiothreitol and 20 mM sodium Pipes (pH 7.4)] containing
1.5% (w/v) CHAPS and 5 mg/ml phosphatidylcholine [95%
(w/w) soya-bean phosphatidylcholine] for 1 h at 4 ◦C. After fur-
ther incubation of the solubilization mixture (3.5 ml aliquot)
with 2 nM [3H]ryanodine for 1 h at 23 ◦C and for 1 h on ice to
monitor the extent of RyR1 solubilization and migration of the
solubilized RyR on sucrose gradients, CHAPS-insoluble material
was removed by centrifugation at 80000 g for 30 min. The super-
natant was layered (approx. 3.5 ml each) on the top of linear gradi-
ents made up of 17 ml of a 7% (w/v) sucrose solution in buffer
A containing 1% CHAPS and 5 mg/ml phosphatidylcholine, and
17 ml of a 15% (w/v) sucrose solution in buffer A containing
0.5% CHAPS and 5 mg/ml phosphatidylcholine. The gradients
were centrifuged at 4 ◦C in a Beckman SW28 rotor (Palo
Alto, CA, U.S.A.) at 26000 rev./min for 16 h, followed by
fractionation into 2 ml fractions, and each fraction was used to
determine the position of bound 3H radioactivity on the sucrose
gradient. Unlabelled receptor peak fractions (without adding
[3H]ryanodine) were pooled, concentrated using a Centriprep
30 concentrator (Amicon, Bedford, MA, U.S.A.) and stored at
−70 ◦C before use.
Planar lipid bilayer
Single-channel recordings of rabbit skeletal RyR1 incorporated
into the planar lipid bilayer were carried out as described prev-
iously [21–23]. Lipid bilayers, consisting of brain tissue phospha-
tidylethanolamine and phosphatidylserine (1:1) in decane (20 mg/
ml), were formed across a hole of approx. 200 µm diameter.
Thinning of the bilayer was monitored by bilayer capacitance. The
basic composition of the cis/trans solution was 300 mM caesium
methanesulfonate, 10 mM Tris/Hepes (pH 7.2) and 10 µM free
Ca2+ [23]. Incorporation of ion channels was carried out as
described by Miller and Racker [21] and confirmed by recording
the characteristically high single-channel conductance of the
RyRs [20,23]. The trans side was maintained at ground and the cis
side was clamped at −30 mV relative to the ground. The effects
of DIDS, caffeine, ryanodine, Ruthenium Red, GAPDH, malate
dehydrogenase, adenylate kinase and aldolase on channel activity
were tested by their addition to the cis side, which corresponded to
the cytoplasmic side of the SR membrane. Solutions with different
free-Ca2+ concentrations were prepared by varying the ratio of
EGTA and CaCl2 concentrations, as described previously [19].
DIDS-affinity column chromatography
Dry CNBr-activated Sepharose 4B beads were allowed to swell in
a buffer composed of 50 mM sodium carbonate (pH 9) and reacted
with 10 mM 1,5-diaminopentane for 36 h at 4 ◦C [24]. The beads
were washed several times with the same buffer and reacted with
3 mM DIDS at 4 ◦C for 48 h (DIDS-affinity beads). After packing
of the beads in a column (6 cm in length and 2.3 cm in diameter),
DIDS-affinity column was washed with >50 volumes of the
column buffer composed of 10 mM Tris/HCl (pH 7.4), 0.5 M
NaCl and 1% (v/v) Nonidet P40 at 4 ◦C. Nonidet P40 (1 %)-
solubilized junctional SR was passed through the equilibrated
DIDS-affinity column. The column was washed with another
20 volumes of the column buffer until the A280 had returned to a
stable baseline, and then the column-bound proteins were eluted
with the column buffer containing 0.5–2 M KCl.
Aldolase-affinity batch-column chromatography
Dry CNBr-activated Sepharose 4B beads (0.1 g) were allowed to
swell in 1 mM HCl for 20 min at 0 ◦C, and then washed several
times with coupling buffer composed of 100 mM carbonate
(pH 8.3) and 0.5 M NaCl. The beads were suspended in coupling
buffer with 5 mM rabbit skeletal aldolase for 16 h at 4 ◦C
(aldolase-affinity bead), and the beads were incubated with a
blocking buffer composed of 1 M ethanolamine (pH 8.0) and
0.5 M NaCl for 16 h at 4 ◦C to block any remaining active
groups. Excess ligands were removed by alternative washing
with coupling buffer and then with a solution of 0.1 M acetate
(pH 4.0) and 0.5 M NaCl. For batch-column chromatography,
solubilized junctional SR vesicles (250 µg) in 20 mM Tris/HCl
(pH 7.4), 0.5 M NaCl and 1 % (v/v) Triton X-100 were incubated
for 4 h at 4 ◦C with the aldolase-affinity beads (10 µg). The
protein–bead complexes were washed repeatedly with PBS
[137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 (pH 7.4) and
2 mM KH2PO4] containing the protease inhibitor cocktail (Roche
Applied Science, Penzberg, Germany) to remove non-specifically
bound proteins. The affinity-bead-bound proteins were boiled
(100 ◦C for 10 min) in the SDS sample buffer and subjected to
SDS/PAGE [7.5 or 10% (w/v) gel] for immunoblot analysis with
anti-RyR1 or anti-aldolase antibodies.
2D (two-dimensional) PAGE and MS analysis
CHAPS-solubilized proteins (80 µg) were adsorbed on to 13 cm
IPG (immobilized pH gradient) strips (pH 3–10) and then
subjected to isoelectric focusing on an IPGphor IEF unit
(Amersham Biosciences). The focused IPG strips were placed
on to 12.5 % acrylamide gel and the proteins separated by
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SDS/PAGE (15 mA/gel). Spots of interest were manually excised
from silver-stained 2D gels and processed according to standard
methods [25,26]. MALDI–TOF (matrix-assisted laser-desorp-
tion ionization–time-of-flight) MS analyses were performed on
a Voyager-DE STR mass spectrometer (PerSeptive Biosystems,
Framingham, MA, U.S.A.), operated in the delayed extraction
and reflector mode. Tandem mass sequencing analysis was carried
out using the MALDI–TOF mass spectrometer 4700 Proteomics
Analyzer (Applied Biosystems). Spectra were calibrated using a
matrix and tryptic autodigestion ion peaks as internal standards.
Peptides selected from the tandem MS analysis were sequenced
by using fragmentation by low-energy collision-induced dissoci-
ation. The peptide sequence was manually deduced from the
labelled b and y ions (corresponding to N- and C-terminal peptide
fragments) in the collision-induced dissociation fragmentation
spectrum. The peptide masses were used for searches with the MS-
Fit/NCBInr developed at University of California at San Fransisco
Mass Spectrometry Facility (http://prospector.ucsf.edu).
[3H]Ryanodine-binding assay
DIDS-and/or aldolase-activated [3H]ryanodine binding was mea-
sured as described previously [27]. Briefly, equilibrium ryanodine
binding to SR was performed by incubation of 0.05 mg of SR in
250 µl of reaction mixture containing 0.2 M KCl, 20 mM Mops,
1 nM [3H]ryanodine and 10 µM free Ca2+ (pH 7.3) for 2 h at
37 ◦C. PEG [poly(ethylene glycol)] solution [100 µl; 30% (w/v)
PEG, 1 mM EDTA and 50 mM Tris/HCl (pH 7.3)] was added
to each vial and further incubated for 5 min at room temperature
(25 ◦C). Precipitated protein was sedimented for 5 min at 12000 g
in an Eppendorf microcentrifuge, and the pellets were rinsed
twice with 0.4 ml of the appropriate ryanodine-binding buffer
without radioactive ryanodine. The pellets were then solubilized
in 100 µl of Soluene 350 (Packard, Boston, MA, U.S.A.) at
70 ◦C for 30 min and then radioactivity was counted with 4 ml
of Picofluor (Packard) by a liquid scintillation counter. For non-
specific binding, a 1000-fold amount of non-radioactive ryanodine
(Calbiochem, La Jolla, CA, U.S.A.) was included. In the case of
purified RyR1, 5 µg of purified RyR1 was used with 0.4 mg/ml
BSA. For the PEG solution, BSA and γ -globulin (5 mg of each
per ml) were used as carrier proteins.
Co-immunoprecipitation studies
HSR vesicles (1 mg/ml) were solubilized in a solution containing
0.1 M NaCl, 1% CHAPS and 20 mM Tris/HCl (pH 7.4) on ice for
1 h. For co-immunoprecipitation studies, the CHAPS-solubilized
junctional SR fraction was centrifuged at 20000 g in a Beckman
Ti70 rotor for 20 min at 4 ◦C, and the supernatant was incubated
at 4 ◦C for 4 h with a monoclonal anti-RyR1 or anti-aldolase
antibody, followed by incubation with Protein G–Sepharose
affinity beads at 4 ◦C for 4 h. The protein–bead complexes
were washed repeatedly with 0.1 % CHAPS/PBS solution with
protease inhibitors to remove non-specifically bound proteins. The
bound proteins were subjected to SDS/PAGE and immunoblot
analysis with the anti-RyR1 or anti-aldolase antibody.
Statistical analysis
Results are expressed as the means +− S.E.M. Significance
differences were analysed by paired or unpaired Student’s t test
and ANOVA. Differences were considered to be significant when
P < 0.05. EC50 values for the RyR1 agonists were calculated using
the Hill equation. The fitting of data to the graphs were carried
out using Origin v7.
Figure 1 Single native RyR1 channels are activated by DIDS
(A) Channel current traces of a single native RyR1 activated by various concentrations of DIDS
(0, 1, 10, 50 or 100 µM) are shown. DIDS was added to the cis side to activate the channel in
the presence of 10 µM free Ca2+ . Single-channel currents are shown as downward deflections
from the closed level (indicated by c). Channel activities were recorded at a holding potential of
−30 mV. (B) The plot of Po versus various concentrations of DIDS is shown. The numerals and
denominators shown in the parentheses represent the number of channels showing a reversibility
and the number of channels used for the experiments respectively. The activity was monitored for
over 120 s in each condition. The average Po obtained at 10 µM Ca2+ was 0.15 +− 0.02, which
increased to 0.19 +− 0.04, 0.44 +− 0.04, 0.65 +− 0.03, 0.71 +− 0.03, 0.78 +− 0.04 and 0.88 +− 0.05
after addition of 1, 10, 30, 50, 75 and 100 µM DIDS respectively. At 1, 10 and 30 µM DIDS,
the average Po fell to 0.17 +− 0.02, 0.15 +− 0.06 and 0.18 +− 0.03 respectively, after washing
out DIDS with the cis solution for 2 min (reversible). On the other hand, at 50, 75 and 100 µM
DIDS, the average Po became 0.55 +− 0.08, 0.68 +− 0.05 and 0.80 +− 0.06 respectively, after the
washing out (irreversible).
RESULTS
Effects of DIDS on single-channel properties of RyR1
using SR vesicles (native RyR1)
To examine how DIDS alters RyR1 channel activity, HSR vesicles
from rabbit skeletal muscle were incorporated into planar lipid
bilayers, and the single-channel properties of the native RyR1
were examined. The chamber solution for both cis and trans sides
included 300 mM caesium methanesulfonate, 10 mM Tris/Hepes
(pH 7.2) and 10 µM free Ca2+. DIDS was added to the cis (cyto-
solic) side. Figure 1(A) shows the typical channel current traces
of a single native RyR1 activated by various concentrations of
DIDS (0–100 µM). Channel activity was monitored at a holding
potential of −30 mV for over 120 s for each condition. The
mean Po was 0.175 +− 0.080 in the absence of DIDS, and 0.451 +−
0.038 and 0.850 +− 0.032 after addition of 10 and 100 µM DIDS
respectively (Figure 1 and see Supplementary Table 1 at http://
www.BiochemJ.org/bj/399/bj3990325add.htm). The increased Po
by 10 µM DIDS was accompanied by a pronounced change in
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Figure 2 Ca2+-dependence of single native RyR1 activation in the presence of DIDS
(A) Single-channel currents were recorded at various concentrations of Ca2+, as indicated, without (control) or with 10 µM DIDS. Single-channel currents are shown as downward deflections from
the closed level (indicated by c). (B) Plots of Po versus Ca2+ concentration without () or with () 10 µM DIDS are shown. Current recordings were obtained at −30 mV. The results are expressed
as the means +− S.E.M. for 5 independent experiments.
Figure 3 Effect of DIDS on purified RyR1
(A) Single-channel activity of purified RyR1 was recorded with 10 µM Ca2+ without (control) or with DIDS (10–100 µM). Single-channel currents are shown as downward deflections from the
closed level (indicated by c). The holding potential was −30 mV. Note that the extent of channel activation by 10 µM DIDS was considerably lower in purified RyR1 compared with native RyR1 in
Figure 1. (B) Native RyR1 or purified RyR1 was activated or modified by serial addition of 10 µM Ca2+, 3 mM caffeine, 10 µM ryanodine and 5 µM Ruthenium Red. Note that the patterns of the
activation and modification by Ca2+ , caffeine, ryanodine and Ruthenium Red are similar between native and purified RyR1s (Supplementary Table 1).
open and closed time constants (Supplementary Table 1). The
most outstanding effect was an appearance of the new third open
time (τo3 = 16.820 +− 5.340) and closed time (τc3 = 29.067 +−
11.643) components.
Figure 1(B) shows the DIDS concentration-dependence of
RyR1 on Po measured in the presence of 10 µM Ca2+. A fitting
of the curve suggested two phases, an exponential phase at 1–
30 µM DIDS and a linear phase at >30 µM DIDS. We examined
the reversibility of DIDS-activated RyR1 by washing out DIDS
with the cis solution for 2 min. Most of the RyR1s exposed to
1–30 µM DIDS were reversible (ten channels from a total of
11), but they became irreversible at the higher concentrations
(two channels from a total of ten) (Figure 1B, frequencies of
reversibility in parentheses). Therefore the two distinct phases
appeared to be linked to the mechanisms responsible for the
reversible and irreversible activation of RyR1.
Ca2+-dependent activation of native RyR1 in the presence of DIDS
Figure 2(B) shows bell-shaped Ca2+-dependence curves of native
RyR1 in the absence and presence of 10 µM DIDS (Fig-
ure 2A). Addition of 10 µM DIDS to the cis side increased both
the ascending and descending phases of the Ca2+-activation/
inhibition curve (Figure 2B) and reduced Ca2+ concentration to
produce half maximal activation of native RyR1 [EC50 values with
(10 µM) and without DIDS respectively: 1.68 +− 1.02 µM com-
pared with 11.48 +− 5.62 µM], suggesting that DIDS increased the
Ca2+ affinity to native RyR1.
DIDS has a much less potent effect on purified RyR1
We incorporated purified RyR1 into lipid bilayers to determine
whether the activation of native RyR1 by DIDS (Figures 1 and 2)
was due to a direct activation of RyR1 by DIDS or to an indirect
activation by another protein associated with RyR1, as proposed
by other groups previously [10,11,14–18]. Unlike native RyR1
shown in Figure 1, addition of DIDS at a concentration between
10 and 100 µM to the cis side in the presence of 10 µM Ca2+
led to only a small increase in Po (Figure 3A, and see Figure 5A,
right-hand panel). DIDS also failed to significantly affect the
gating properties of purified RyR1 (Supplementary Table 1).
The pronounced appearance of the third component (τo3) in
native RyR1 in response to 10 µM DIDS was absent in the purified
RyR1, indicating that the effectiveness of DIDS was considerably
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Figure 4 DIDS-affinity column chromatography for identifying the DIDS-binding protein(s)
(A) HSR (lane 1), CNBr-bead-binding proteins (lane 2), DIDS-affinity bead-unbound proteins (lane 3) and DIDS-affinity bead-bound proteins (lane 4) (80 µg of each) were separated by SDS/PAGE
(10 % gel), and then the gels were stained with Coomassie Blue. The protein yield of the DIDS-binding proteins was approx. 3 % of the SR proteins loaded on to the affinity gel. (B) Silver-stained 2D
gel showing the proteins bound to the DIDS-affinity beads. Major four protein bands in lane 4 (A) were identified as aldolase, malate dehydrogenase, GAPDH and adenylate kinase by MALDI–TOF MS
analysis. The colorimetric development of the protein spots was stopped when the major proteins appeared. (C) Channel current traces of a single purified RyR1 activated by one of four DIDS-binding
proteins in the presence of 10 µM Ca2+ are shown. Each DIDS-binding protein (35 µg/ml) was added to the cis side.
decreased in purified RyR1. On the other hand, 3 mM caffeine
increased Po both in native and purified RyR1 to a similar extent
(Supplementary Table 1). In addition, the single RyR1 currents
activated by 10 µM Ca2+ were locked in a subconductance state
by 10 µM ryanodine and completely blocked by 5 µM Ruthenium
Red both in native and purified RyR1 (Figure 3B), suggesting that
the properties of RyR1 responding to the pharmacological agents
was not changed by the purification process.
Identification of the DIDS-bound proteins
We attempted to isolate and characterize DIDS-binding protein(s)
in HSR by DIDS-affinity column chromatography using deter-
gent-solubilized HSR vesicles. We prepared a DIDS-affinity
column composed of DIDS–diaminopentane-linked CNBr-
Sepharose 4B [24]. The method was especially useful for the iso-
lation of reversibly interacting proteins to DIDS, since the
S=C=N groups located on both sides of DIDS molecules are
supposed to be masked by CNBr-Sepharose molecules, so that
only reversibly bound proteins could be recovered from the
gel matrix when eluted. Figures 4(A, lane 4) and 4(B) show
the representative 1D or 2D gel of the affinity-purified DIDS-
binding proteins. To identify the major DIDS-binding proteins
shown in Figures 4(A, lane 4) and 4(B), gel slices containing the
corresponding bands and spots were digested with trypsin, and
then subjected to MALDI–TOF MS analysis, as described in the
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Figure 5 DIDS dependence of purified RyR1 channel activity in the presence or absence of aldolase
(A) Channel current traces of a single purified RyR1 were recorded in the presence of various concentrations of DIDS (10 to 100 µM) with 35 µg/ml aldolase (left-hand panel). Plots of Po versus
various concentrations of DIDS in the absence () and presence () of aldolase are shown (right-hand panel). The results are expressed as the means +− S.E.M. The number of observations were
7, 7, 6 and 5 for 0, 10, 50 and 100 µM DIDS respectively in the presence of 35 µg/ml aldolase. (B) Channel current traces of single purified RyR1 were recorded in the presence of increasing
concentrations of aldolase (0 to 75 µg/ml). The plot of Po versus various concentrations of aldolase is shown. The results are expressed as the means +− S.E.M. for 5 independent experiments.
Experimental section. Four major DIDS-binding proteins from
HSR were identified: 40 kDa aldolase (NCBI accession num-
ber 13096351), 38 kDa malate dehydrogenase (NCBI accession
number 65932), 37 kDa GAPDH (NCBI accession number
6016083) and 27 kDa adenylate kinase 1 (NCBI accession num-
ber 125152). Additional minor DIDS-binding proteins, such as
RyR1 and chloride channel type 1, were also identified by
Western-blot analysis.
Recovery of the DIDS sensitivity of purified RyR1 by aldolase
To test whether one of the four DIDS-binding proteins in HSR
identified by DIDS-affinity column chromatography, as described
above, could confer DIDS sensitivity to purified RyR1, each
DIDS-binding protein was added to cis side of RyR1 incorporated
into lipid bilayers in the presence or absence of 10 µM DIDS
(Figure 4C). We found that only aldolase increased Po of RyR1
in the presence of DIDS, although aldolase by itself did not
change Po of RyR1 (Supplementary Table 2 at http://www.
BiochemJ.org/bj/399/bj3990325add.htm).
A detailed study of aldolase-mediated RyR1 activation by DIDS
was examined by measuring single-channel properties of purified
RyR1 in the presence of aldolase. Figure 5(A, left-hand panel)
shows representative current records of a single purified RyR1
measured in the presence of increasing concentrations of DIDS
at a fixed concentration of aldolase (35 µg/ml). The channel
activity was monitored at a −30 mV holding potential for over
120 s in each condition. The channel activity in the presence of
aldolase was significantly higher than that measured in the absence
of aldolase at all the DIDS concentrations tested (Figure 5A,
right-hand panel). However, aldolase by itself in the concentration
range between 15 and 75 µg/ml did not significantly affect
channel activity (Figure 5B).
To obtain a clearer picture of the single-channel events leading
to the increased activation of RyR1 by DIDS in the presence of
aldolase, we performed lifetime analysis of single purified RyR1
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Figure 6 Effects of DIDS on [3H]ryanodine binding to native and purified
RyR1s in the presence or absence of aldolase
Equilibrium [3H]ryanodine binding to native (A) or purified (B) RyR1s was performed as
described in the Experimental section in the presence of 10 µM free Ca2+ without () or
with () 35 µg/ml aldolase. With purified RyR1, 30 µM DIDS in the presence of 35 µg/ml
aldolase induced a greater increase in activity compared with the absence of aldolase. The
control is the specific [3H]ryanodine binding in the presence of 10 µM free Ca2+ (pH 7.3).
Specific [3H]ryanodine binding at the various concentration of DIDS with or without aldolase is
expressed as a percentage of the control. *Significantly different between the two experimental
groups (unpaired Student’s t test, P < 0.05). The results are expressed as the means +− S.E.M.
for 5 independent experiments.
(Supplementary Table 1). The results indicate that the single-
channel properties measured after the addition of aldolase to the
cis solution containing 10 µM DIDS were similar to those found
in the native RyR1, implying that aldolase is the protein conferring
DIDS sensitivity in the native SR.
DIDS dependence of [3H]ryanodine binding to native and purified
RyR1 in the presence of aldolase
Potentiation of the effect of DIDS on RyR1 by aldolase
(Figure 5B) was further confirmed by [3H]ryanodine binding
to both native (Figure 6A) and purified RyR1 (Figure 6B).
The DIDS-concentration dependence of [3H]ryanodine binding
to native RyR1 showed that an addition of aldolase (35 µg/ml)
did not change the concentration dependence of [3H]ryanodine
binding (Figure 6A). On the other hand, DIDS-concentration
dependence of [3H]ryanodine binding to purified RyR1 showed
a significantly elevated [3H]ryanodine binding at all of the
Figure 7 Co-immunoprecipitation of RyR1 with aldolase
The anti-RyR1 antibody (A) or anti-aldolase antibody (B) with Protein G–Sepharose affinity
beads was incubated with solubilized SR (100 µg), and the immunoprecipitates were subjected
to immunoblot analysis with the anti-RyR1 or anti-aldolase antibody. Lane 1, HSR (10 µg);
lane 2, immunoprecipitates from mouse pre-immune serum (A) or goat pre-immune serum
(B); lane 3, immunoprecipitates from the anti-RyR antibody (A) or anti-aldolase antibody (B).
tested DIDS concentrations by addition of aldolase (Figure 6B),
confirming that the presence of aldolase potentiates the
responsiveness of RyR1 to DIDS. The reason for the decreased
[3H]ryanodine binding to purified RyR1 at DIDS concentrations
over 50 µM (Figure 6B) remains unclear.
Direct interaction between RyR1 and adolase
Previously, Brandt et al. [28] have already shown an interaction
between aldolase and RyR1, employing affinity-chromatography
and protein-overlay techniques. In the present study, we first
conducted co-immunoprecipitation assay using 1% CHAPS-
solubilized SR (Figure 7). Aldolase was co-immunoprecipitated
using the anti-RyR1 antibody (Figure 7A), and RyR1 was also co-
immunoprecipitated with the anti-aldolase antibody (Figure 7B),
confirming that aldolase physically interacts with RyR1.
Secondly, the interaction between RyR1 and aldolase was
further investigated by aldolase-affinity batch-column chroma-
tography using detergent-solubilized junctional SR in the pres-
ence or absence of DIDS. The conjugation of aldolase to the
affinity-column beads was confirmed by immunoblot analysis
with the anti-aldolase antibody (Figure 8A, lane 3). It appears
that the proteins bound covalently to the aldolase-affinity beads
were detachable after boiling for 10 min in the Laemmli SDS
sample buffer, as shown previously [29]. The aldolase-affinity
batch column incubated with solubilized junctional SR showed
an interaction of RyR1 with aldolase (Figure 8B, lane 4). To test
whether the presence of DIDS could affect the interaction between
aldolase and RyR1, the same experiment was conducted in the
presence of 100 µM DIDS (Figure 8B, lane 5). The results showed
that the association of aldolase with RyR1 was not affected by the
presence of DIDS (Figure 8B, lane 5), suggesting that DIDS and
aldolase do not share the same binding site on RyR1.
c© 2006 Biochemical Society
332 I.-R. Seo and others
Figure 8 Aldolase-affinity batch-column chromatography
(A) SR (lane 1), purified aldolase (lane 2) and CNBr-bead-detached aldolase (lane 3) (30 µg of
each) were separated by SDS/PAGE (10 % gel) and the gels were stained with Coomassie Blue.
(B) Aldolase-affinity beads were incubated with Triton X-100-solubilized native SR. The bound
proteins were eluted by SDS sample buffer, separated by SDS/PAGE (7.5 % gel) and subjected
to immunoblot analysis with anti-aldolase or anti-RyR antibodies. Lane 1, SR (10 µg); lane 2,
purified aldolase (1 µg); lane 3, aldolase-affinity beads alone (2 µg); lane 4, aldolase-affinity
bead-bound RyR1 in the absence of DIDS; lane 5, aldolase-affinity bead-bound RyR1 in the
presence of 100 µM DIDS.
DISCUSSION
In previous studies, it has been reported that the stilbene-derivative
DIDS could activate RyRs from both skeletal and cardiac muscles
[8,9,12,16,17]. By various biochemical studies, a 30 kDa protein
was identified as a calsequestrin-binding protein, a junction-like
protein or ADP/ATP translocase [16,17], and was also assumed to
be a DIDS-receptor protein that confers DIDS sensitivity to RyRs
[16,17]. However, until now the identity of the 30 kDa protein has
remained to be elucidated.
In the present study, we used both native and purified RyR1s
from rabbit skeletal junctional SR for measurements of the single-
channel properties in planar lipid bilayers. We found that there
were substantial differences in the effect of 10 µM DIDS on RyR1
after purification procedures of RyR1. DIDS had a consider-
ably weaker potentiation on purified RyR1, as shown by a con-
siderably smaller increase in Po,max. The mean open and closed
time constants and their proportions after 10 µM DIDS activation
were also significantly different between native and purified RyRs
(Supplementary Table 1). On the other hand, both native and
purified RyRs showed similar responses to caffeine, ryanodine
and Ruthenium Red (Figure 3), suggesting that the difference in
DIDS sensitivity was not due to any conformational changes
of RyR1 during RyR1 purification. Therefore we postulated that
a DIDS-binding protein essential for DIDS sensitivity of RyR1
was lost during RyR1 purification.
Identification of DIDS-binding protein(s) in SR responsible
for the activation of RyR1 has been controversial, due probably
to the complex binding patterns of DIDS [10–12,15–18]. In the
present study, we re-examined the identity of DIDS-binding pro-
teins using a DIDS–diaminopentane-linked CNBr-Sepharose 4B
affinity column [24]. The method was especially useful to isolate
reversibly interacting DIDS-binding proteins, due to the prior
covalent bond formations between the S=C=N residues of DIDS
molecules and CNBr-Sepharose molecules. This isolation tech-
nique could also minimize the appearance of false-positive DIDS-
binding proteins due to any non-specific covalent bond formation.
With the DIDS-affinity chromatography, we have identified four
major DIDS-binding proteins (40 kDa aldolase, 37 kDa malate
dehydrogenase, 37 kDa GAPDH and 27 kDa adenylate kinase 1),
which are soluble enzymes in the cytosol (Figure 4). The entirely
different protein profiles between the CNBr-Sepharose-bound
fraction (Figure 4A, lane 2) and the DIDS-affinity-column-
bound fraction (Figure 4A, lane 4) indicate that the affinity column
was specific.
In order to investigate whether one of the identified DIDS-
binding proteins in HSR (Figure 4) confers DIDS sensitivity to
RyR1, each of the four DIDS-binding proteins in high purity
was tested on the single-channel properties of purified RyR1 in
bilayers. Surprisingly, among the four DIDS-binding proteins,
aldolase substantially potentiated the channel activity of RyR1
(Figure 4C and Supplementary Table 2). The lifetime of single-
channel properties for the aldolase-added RyR1 were carefully
analysed (Supplementary Table 1). Po was considerably increased
by the addition of 35 µg/ml aldolase, due mainly to the occurrence
of the third components in the open and closed time constants.
It is important to note that the effects of DIDS on purified RyR1
became remarkably similar to native RyR1 by the addition of
aldolase (Supplementary Table 1). Addition of aldolase alone
(15–75 µg/ml) did not significantly alter Po of RyR1 within
the experiment time (30 s stirring plus 2 min of measurement).
Potentiation of the effects of DIDS on RyR1 was also observed
by a [3H]ryanodine-binding study, although the experimental vari-
ations were somewhat greater than the single-channel study.
Studies by Sitsapesan and co-worker have demonstrated that
RyR2s in sheep hearts could be reversibly activated at lower
DIDS concentrations (e.g. 50 µM), but irreversibly activated at
the higher DIDS concentrations (e.g. 500 µM) [10,11]. It was
also found that 1–5 mM DIDS modified both native and purified
RyR2 from sheep heart in a similar manner, suggesting that, at
high irreversible DIDS concentrations, the major modification
site(s) is on the RyR1 molecule itself. Our present observations
also indicated that RyR1 could become reversible or irreversible
depending on the activating DIDS concentrations (Figure 1B).
The Ca2+-dependence of RyR1 activation was also differently
modulated by reversible (Figure 2B) or irreversible concentrations
of DIDS [13]. Taken together, DIDS could activate RyR1 by two
different mechanisms: (i) the reversible interaction through the
mediation of aldolase, and (ii) the irreversible interaction through
RyR1 itself.
The specific interaction between RyR1 and aldolase has been
reported previously by Brandt et al. [28], using immuno-af-
finity chromatography. In the present study, the direct physical
interaction between the two proteins was further confirmed by co-
immunoprecipitaion assay (Figure 7) and aldolase-affinity batch-
column chromatography (Figure 8). According to our CD study,
the spectral changes were observed upon DIDS binding to aldolase
(I. Seo and D.H. Kim, unpublished work), suggesting that aldo-
lase undergoes a substantial conformational change by DIDS
binding.
The specific association of glycolytic and glycogenolytic en-
zymes with SR membranes and evidence that the enzymes
may participate in striated muscle E–C coupling have been
reported by various groups [28,30–32]. For example, enzymes
such as phosphoglycerate kinase, glycogen synthase, glycogen-
debranching enzyme and glucose 6-phosphatase have been
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reported to be associated with SR and ER (endoplasmic reticulum)
[32,33]. It appears that the functions of these enzymes in SR are
related to the production of ATP by glycolysis and therefore to
supply energy to the SR Ca2+-ATPase [30,31]. It has been also
suggested that specific glycolytic enzymes directly participate in
the association between transverse tubules and junctional SR. An
isoform of phosphoglucomutase could be involved in the regula-
tion of SR functions [34–36], and the entire chain of glycolytic
enzymes, including aldolase, is bound to both cardiac and skeletal
muscle SR [28,37]. It is also interesting to note that aldolase can
bind Ins(1,4,5)P3 in large quantities in porcine tracheal smooth
muscle, suggesting the multi-functional role of aldolase [38].
The present study demonstrates that aldolase is associated
with RyR1 and confers the considerable potentiation of DIDS
sensitivity to RyR1. Elucidation of the molecular mechanism for
the potentiation by aldolase must await further studies in the
future. Since DIDS is not a physiological ligand, it is of interest
to identify an endogenous DIDS-like compound in intact muscle
cells.
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